Advertisement
Singapore markets open in 6 hours 42 minutes

  • Straits Times Index

    3,307.90
    -6.15 (-0.19%)
     

  • S&P 500

    5,298.53
    -22.88 (-0.43%)
     

  • Dow

    39,650.81
    -222.18 (-0.56%)
     

  • Nasdaq

    16,757.58
    -75.04 (-0.45%)
     

  • Bitcoin USD

    69,549.63
    -102.60 (-0.15%)
     

  • CMC Crypto 200

    1,514.77
    -11.64 (-0.76%)
     

  • FTSE 100

    8,370.33
    -46.12 (-0.55%)
     

  • Gold

    2,392.90
    -33.00 (-1.36%)
     

  • Crude Oil

    77.58
    -1.08 (-1.37%)
     

  • 10-Yr Bond

    4.4240
    +0.0100 (+0.23%)
     

  • Nikkei

    38,617.10
    -329.83 (-0.85%)
     

  • Hang Seng

    19,195.60
    -25.02 (-0.13%)
     

  • FTSE Bursa Malaysia

    1,622.09
    -5.41 (-0.33%)
     

  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     

  • PSE Index

    6,607.22
    -26.44 (-0.40%)
     

Portfolio Update

Oxford Technology 4 VCT plc
·1-min read

The Board notes that on 3 June 2021 Arecor Therapeutics plc ("Arecor"), one of Oxford Technology 4 VCT Plc’s (“OT4”) investee companies, floated on AIM raising £20m via a placing at 226p per Arecor share. The flotation was a success and the Arecor bid price at close had risen to 238p per Arecor share.

The most recently published unaudited net asset value (NAV) for OT4 at 30 November 2020 was 28.8p per share.

Compared to this last published OT4 NAV, the impact of the Arecor flotation in isolation is an increase in the OT4 NAV of £673k, or 5.8p per OT4 share.

Further detail – including an updated OT4 NAV as at 28 February 2021 and 31 May 2021 – will be available in the annual report which is expected to be released towards the end of this month.

For further information contact:

Oxford Technology Management

Lucius Cary

01865 784466